Asia Pacific Apheresis Equipment Market value was valued at USD 689.1 million in 2019 and is expected to witness over 12.3% CAGR from 2019 to 2026.
Get more details on this report - Request Free Sample PDF
Increasing disease burden coupled with safety concern will foster the market growth expansion. Rising demand for platelets and high unmet needs in the region is expected to render significant growth opportunities in the future. Moreover, advanced technology in apheresis devices such as graphical user interface display, screen navigation and automated interface system reduces human interventions. Such technologies provide effective results, thus, driving the market growth.
Emerging geriatric population is highly susceptible to various chronic disease as well as blood disorders such as sickle cell anemia and hemophilia among others. For instance, chronic kidney disease is a major health burden among the Chinese population. Furthermore, growing incidence of rare diseases that can be treated by apheresis technique will offer lucrative growth opportunities to apheresis equipment market. However, lack of donor availability may restrain the industry growth.
Asia Pacific Market Share, By Product
Based on product, the apheresis equipment market is further segmented into disposable apheresis kits and apheresis machines. The apheresis machines segment held a significant revenue in 2019 and estimated to show over 15.0% CAGR during the forthcoming years. Apheresis machines are used during transfusion procedures and assist in separation of blood components. Furthermore, wide availability of apheresis machines manufactured by numerous players across the region will influence robust market growth.
Asia Pacific Market Size, By Application
By application, the apheresis equipment market is classified into renal disease, neurology, hematology and others. Neurology segment accounted for USD 356.1 million revenue size in 2019 and will witness substantial growth by 2026. Globally, increasing prevalence of neurological ailments including multiple sclerosis, enhance the demand for blood-based products, in turn impacting the adoption rate of apheresis equipment.
Asia Pacific Market Value, By Procedure
Based on procedure, the apheresis equipment market is divided into photopheresis, plasmapheresis, LDL apheresis, plateletpheresis, leukapheresis and erythrocytapheresis. The photopheresis segment is expected to grow exponentially during the forecast period. High segmental growth is attributed to increasing prevalence of blood-related disorders and growing demand for photopheresis. Treatment such as organ transplant rejection, cutaneous T-cell lymphoma, scleroderma and type 1 diabetes leads to adoption of photopheresis, thus impacting the segment expansion.
Asia Pacific Market Forecast, By Technology
Apheresis equipment market based on technology is segmented as membrane filtration and centrifugation. Centrifugation segment accounted for around USD 278.0 million and is projected to show lucrative growth over the timeframe. Advantages offered by centrifugation apheresis include high efficiency to separate the blood components. Such advantages will pose high segment growth in the future.
Asia Pacific Market Trends, By Country
Japan recorded highest revenue share in 2019 and is forecast to witness around 11.0% CAGR during the analysis period. Increasing prevalence of blood-related disorders and platelet transfusion in the market are key factors accounting for market growth. Additionally, rising number of healthcare professionals and sophisticated healthcare infrastructure will exhibit robust industry growth in the foreseeable future.
Competitive Market Share
Some of the major industry players involved in the market include Asahi Kasei Corporation, Fresenius SE & Co. KGaA, B. Braun Melsungen Ag and Haemonetics Corporation among others. These players are adopting various inorganic strategies such as collaborations, agreements and acquisitions for business expansion.
In emerging economies, the development of apheresis is still evolving. In Indonesia, approximately 204 apheresis procedures were performed in 137 patients to reduce leukocytes. To overcome this, the developing economies is improving installation of apheresis devices. Also, these countries are increasing the insurance coverage and are considering introduction of apheresis into the curriculum of appropriate physician programs. Additionally, several apheresis devices have been developed to ensure high therapeutic efficacy with low adverse events. Thus, increasing awareness about importance of apheresis will augment the adoption of apheresis equipment in the region over the future years.